Company Overview of Precision BioSciences, Inc.
Precision BioSciences, Inc., a biotechnology company, engages in developing and commercializing therapeutics and services based on genomic molecular biology. It offers Biotherapeutics, a directed nuclease editor (DNE) therapeutic targeted to enable the in situ correction of genes responsible for human diseases; Biotools, an engineered DNE meganucleases used to engineer cell lines for disease models or optimize cell lines for the biomanufacturing of protein vaccines and therapeutics; and PlantSciences, a custom DNE meganucleases that enable site-specific engineering of row crops and biofuel feedstock. The company was founded in 2006 and is based in Research Triangle Park, North Carolina.
302 East Pettigrew Street
Dibrell Building Suite A-100
Durham, NC 27701
Founded in 2006
Key Executives for Precision BioSciences, Inc.
Co-Founder, Chief Executive Officer and Director
Chairman and Vice President of Scientific Development
Chief Operations Officer and Chief Financial Officer
Director of Meganuclease Development
Compensation as of Fiscal Year 2014.
Precision BioSciences, Inc. Key Developments
Danziger Innovations Ltd. and Precision BioSciences, Inc. Announce Successful Genome Modification Collaboration in Ornamental Plants
Mar 20 14
Danziger Innovations Ltd. and Precision BioSciences, Inc. announced that they have successfully generated site-specific genome modifications in petunia and jasmine tobacco by combining Precision's Directed Nuclease Editor (DNE) gene editing technology with Danziger's MemoGene gene delivery system. This successful research effort was aimed at genetic control of flower color but researchers at Precision and Danziger believe that the approach can be used more broadly to address genome engineering challenges in plants that are recalcitrant to existing transformation methods without requiring the insertion of foreign DNA into the plant genome.
Nova Synthetix and Precision BioSciences, Inc. Announce Collaboration to Develop Non-GM, Ricin-Free Castor with Customizable Oil Content
Mar 12 14
Nova Synthetix and Precision BioSciences, Inc. announced that they have initiated a joint research effort to generate non-GM, ricin-free castor plants using Precision's Directed Nuclease Editor (DNE) technology in combination with Nova Synthetix's proprietary plant transformation system. Scientists at Nova Synthetix and Precision also plan to utilize their joint capabilities to generate improved castor variants capable of producing user defined oil profiles for industrial, biofuel, and feed-directed applications. The companies believe that the successful development of this multi-year research effort will address a significant agricultural need and result in a castor plant that is safer and has far greater market utility.
Precision BioSciences and Agrivida Announce Collaborative Trait Development Agreement
Mar 10 14
Precision BioSciences and Agrivida revealed that they have entered into a trait development collaboration based on precise gene modifications made possible by Precision's Directed Nuclease Editor Technology. The collaboration recently delivered the first modified genes that are the subject of Agrivida commercialization efforts in the area of animal nutrition.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries